|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.630 USD | +0.77% |
|
+24.06% | -8.68% |
| 07-29 | Processa Pharmaceuticals, Inc. acquired Vidya Therapeutics, Inc. for approximately $320 million. | CI |
| 07-29 | Processa Pharmaceuticals, Inc. - M&A Call |
Chart calendar Processa Pharmaceuticals, Inc.
Upcoming events on Processa Pharmaceuticals, Inc.
No events available
Past events on Processa Pharmaceuticals, Inc.
| 2026-07-30 | Annual General Meeting | 13:00 |
| 2025-09-10 | Extraordinary General Meeting |
Past dividends on Processa Pharmaceuticals, Inc.
| 2025-12-17 | Significant Split/Dividend | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -11,5 -11,2 -2.63% | -12,1 -12,4 2.55% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,1 -10,9 -2.1% | -11,9 -12,2 2.48% |
|
Net income Million USD | Released Forecast Spread | -11,1 -10,9 -2.1% | -11,9 -12,2 2.48% |
|
EPS USD | Released Forecast Spread | -212 -213 0.24% | -96,8 -101 4.44% |
| Announcement Date | 29/03/24 | 20/03/25 |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -3,42 -3,12 -9.77% | -2,73 -3,05 10.34% | -2,85 -2,60 -9.58% | -3,95 -2,68 -47.2% | -3,49 -3,87 9.73% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,38 -3,06 -10.61% | -2,73 -3,03 9.94% | -2,83 -2,60 -9.1% | -3,93 -2,68 -46.73% | -3,44 -3,86 10.99% |
|
Net income Million USD | Released Forecast Spread | -3,38 -3,06 -10.61% | -2,73 -3,03 9.94% | -2,83 -2,60 -9.1% | -3,93 -2,68 -46.73% | -3,44 -3,86 10.99% |
|
EPS USD | Released Forecast Spread | -25,8 -25,0 -3% | -18,5 -23,0 19.57% | -7,50 -12,3 38.78% | -6,25 -5,50 -13.64% | -1,75 -2,00 12.5% |
| Announcement Date | 30/10/24 | 20/03/25 | 08/05/25 | 07/08/25 | 06/11/25 |
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings presentation | 16:30 | |
| Today | Earnings presentation | 16:30 | |
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings presentation | 17:00 | |
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings presentation | 08:30 | |
| 2026-08-13 | Earnings release - Q2 2026 | ||
| 2026-08-13 | Earnings presentation | 16:30 |
Past sector events for Processa Pharmaceuticals, Inc.
| Today | Earnings release - Q2 2026 | ||
| 2026-08-11 | Earnings presentation | 08:00 | |
| 2026-08-11 | Earnings release - Q2 2026 | ||
| 2026-08-11 | Earnings presentation | 16:30 | |
| 2026-08-11 | Earnings release - Q2 2026 | ||
| 2026-08-11 | Earnings release - Q2 2026 | ||
| 2026-08-11 | Earnings presentation | 08:30 | |
| 2026-08-11 | Annual General Meeting | 12:00 | |
| 2026-08-06 | Earnings release - Q2 2026 | ||
| 2026-08-06 | Earnings presentation | 08:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
- Calendar Processa Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
















